Trioar

Trioar

Innovative drug development accelerating research and reducing costs to create a better future for humanity.

HQ location
South Korea
Launch date
Enterprise value
$8—13k
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor

€0.0

round
*

KRW2.5m

Series B
Total Funding000k
Notes (0)
More about Trioar
Made with AI
Edit

Triore is a pioneering drug development company focused on creating innovative pharmaceutical solutions to improve global health. Operating in the biotechnology and pharmaceutical sectors, Triore serves a diverse range of clients including healthcare providers, research institutions, and pharmaceutical companies. The company leverages its advanced research infrastructure and cutting-edge technology to expedite drug development processes while minimizing costs. Triore's business model revolves around research and development (R&D), where it invests in discovering and developing new drugs, which are then licensed or sold to larger pharmaceutical firms. Revenue is generated through licensing agreements, partnerships, and direct sales of developed drugs. The company is committed to its core values of insight, faith, and constant challenge, aiming to create a better future for mankind through its innovative solutions.

Keywords: drug development, biotechnology, pharmaceutical, research, innovation, healthcare, R&D, licensing, partnerships, global health.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads